In accordance with Article 22 of the newly amended Frontier Health and Quarantine Law of the People's Republic of China, this Announcement specifies that goods, articles, and imported biological reagents for environmental protection purposes—which fall under the regulatory scope of pharmaceuticals, veterinary drugs, or medical devices—shall undergo customs inspection and quarantine as ordinary inbound and outbound goods and articles, rather than being regulated as special entry-exit items.